The Effectiveness of Tranexamic Acid in Pediatric Posttonsillectomy Hemorrhage (A Systematic Review and Meta‐Analysis)
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70280 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Maimuna S Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Tonsillectomy, Postoperative Hemorrhage, Antifibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To systematically review the literature regarding the effectiveness of tranexamic acid (TXA) in the management of pediatric post‐tonsillectomy hemorrhage (PTH). Data Sources Comprehensive searches across PubMed, Embase, and Web of Science were conducted through December 2024 in accordance with Preferred Reporting Items for Systematic reviews and Meta‐analyses (PRISMA) guidelines. Review Methods Studies evaluating TXA (any route) for PTH in children aged 2 to 18 years were reviewed. Study characteristics, patient demographics, tonsillectomy technique, postoperative day on presentation, patient exam, route of TXA administration, and dosage were extracted. The primary outcome of interest was the rate of reoperation for hemostasis; secondary outcomes of interest included need for blood transfusion and adverse effects.
Results
Eight studies (n = 801) met inclusion criteria. TXA administration was associated with a significant reduction in reoperation rates for hemostasis (pooled RR = 0.62, 95% CI 0.49‐0.78), with no significant difference between routes of administration. There was no statistically significant difference in transfusion risk (RR = 0.76, 95% CI 0.26‐9.45). Across all studies, no adverse effects attributable to TXA were reported.
Conclusion
TXA use in managing pediatric PTH is associated with a significant reduction in reoperation rates, with both intravenous and nebulized formulations demonstrating similar effectiveness. Nebulized TXA offers practical advantages in pediatric patients and provides potential targeted oropharyngeal delivery. The available evidence is limited by retrospective study designs, small sample sizes, and risk of bias. These findings support the need for prospective studies to standardize assessment and treatment algorithms, optimize management, inform clinical practice guidelines. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.
- Division of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.
ORCID-Profile: Maimuna S Ahmad
Zitieren
APA
Ahmad, M. S., Alosamey, F., & Luu, K. (2026). The Effectiveness of Tranexamic Acid in Pediatric Posttonsillectomy Hemorrhage (A Systematic Review and Meta‐Analysis). Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70280
Vancouver
Ahmad MS, Alosamey F, Luu K. The Effectiveness of Tranexamic Acid in Pediatric Posttonsillectomy Hemorrhage (A Systematic Review and Meta‐Analysis). Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70280
BibTeX
@article{Ahmad2026,
author = {Ahmad, Maimuna S and Alosamey, Faisal and Luu, Kimberly},
title = {The Effectiveness of Tranexamic Acid in Pediatric Posttonsillectomy Hemorrhage (A Systematic Review and Meta‐Analysis)},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70280}
}
EUVIMED